Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1259972.RApza2plnlxMlqNqegtRPdUZNNjSNGny8nNnW6F1UO2C4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1259972.RApza2plnlxMlqNqegtRPdUZNNjSNGny8nNnW6F1UO2C4130_assertion type Assertion NP1259972.RApza2plnlxMlqNqegtRPdUZNNjSNGny8nNnW6F1UO2C4130_head.
- NP1259972.RApza2plnlxMlqNqegtRPdUZNNjSNGny8nNnW6F1UO2C4130_assertion description "[Survival rates of high-risk neuroblastoma remain less than 50%, with amplification of the MYCN oncogene the most important aberration associated with poor outcome.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1259972.RApza2plnlxMlqNqegtRPdUZNNjSNGny8nNnW6F1UO2C4130_provenance.
- NP1259972.RApza2plnlxMlqNqegtRPdUZNNjSNGny8nNnW6F1UO2C4130_assertion evidence source_evidence_literature NP1259972.RApza2plnlxMlqNqegtRPdUZNNjSNGny8nNnW6F1UO2C4130_provenance.
- NP1259972.RApza2plnlxMlqNqegtRPdUZNNjSNGny8nNnW6F1UO2C4130_assertion SIO_000772 25640269 NP1259972.RApza2plnlxMlqNqegtRPdUZNNjSNGny8nNnW6F1UO2C4130_provenance.
- NP1259972.RApza2plnlxMlqNqegtRPdUZNNjSNGny8nNnW6F1UO2C4130_assertion wasDerivedFrom befree-2016 NP1259972.RApza2plnlxMlqNqegtRPdUZNNjSNGny8nNnW6F1UO2C4130_provenance.
- NP1259972.RApza2plnlxMlqNqegtRPdUZNNjSNGny8nNnW6F1UO2C4130_assertion wasGeneratedBy ECO_0000203 NP1259972.RApza2plnlxMlqNqegtRPdUZNNjSNGny8nNnW6F1UO2C4130_provenance.